AVITA Medical, Inc.
RCEL
$4.02
$0.112.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.44% | -0.28% | 18.62% | 35.56% | 25.72% |
| Total Depreciation and Amortization | 20.35% | 58.19% | 85.16% | 170.59% | 156.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.13% | -62.34% | 1.98% | -62.28% | -27.32% |
| Change in Net Operating Assets | -1,025.73% | 640.88% | -59.73% | -3,407.84% | 103.86% |
| Cash from Operations | 2.30% | 32.71% | 27.65% | 19.96% | 50.59% |
| Capital Expenditure | 91.40% | 141.81% | 75.16% | 80.24% | 80.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.25% | -116.24% | -139.51% | -50.01% | -32.23% |
| Cash from Investing | -81.04% | -99.55% | -172.23% | -43.56% | -28.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -75.71% | 1,372.10% | -34.16% | -42.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,579.61% | -75.71% | 1,267.03% | -34.16% | -42.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -335.85% | -12.86% | 170.09% | -629.74% | 115.87% |